01:07 , Jul 15, 2015 |  BC Extra  |  Company News

Management tracks

Baxalta Inc. (NYSE:BXLT) named Jacopo Leonardi EVP and president of immunology. Leonardi most recently was general manager of U.S. Hemophilia at the Baxter BioScience unit of Baxter International Inc. (NYSE:BAX). Antares Pharma Inc. (NASDAQ:ATRS) hired...
07:00 , Mar 16, 2015 |  BC Week In Review  |  Company News

14M Genomics, EORTC deal

14M Genomics and the European Organization for Research and Treatment of Cancer (EORTC) partnered to use genomic diagnostic profiles to facilitate enrollment into clinical trials for cancer. 14M Genomics will conduct genomic variation analysis on...
07:00 , Mar 16, 2015 |  BioCentury  |  Emerging Company Profile

Genomic-linked outcomes

14M Genomics Ltd. aims to improve the prognostic value of cancer genome profiling by linking a patient's genomic signature with clinical outcomes compiled from large data sets. 14MG's tests use next-generation sequencing combined with...
08:00 , Feb 16, 2015 |  BC Week In Review  |  Company News

14M Genomics, University of York deal

14M Genomics and the university’s Haematological Malignancy Research Network partnered to improve diagnostic and clinical pathways for patients with blood and lymphatic cancers by analyzing over 20,000 samples from blood cancer patients. According to 14M,...
08:00 , Feb 5, 2015 |  BC Innovations  |  Finance

PPPs holding steady

BioCentury's annual analysis of public-private partnerships and early stage venture financing activity shows that the model of using PPPs to foster academic innovation is holding fast, and that academia is an active driver behind the...
08:00 , Dec 22, 2014 |  BC Week In Review  |  Financial News

14M Genomics completes venture financing

14M Genomics Ltd., Hinxton, U.K.   Business: Diagnostic   Date completed: 2014-12-16   Type: Venture financing   Raised: £12.5 million ($19.7 million)   Investor: Syncona Partners LLP   ...